首页> 外文期刊>Clinical and Translational Medicine >Potential biomarkers and targets of mitochondrial dynamics
【24h】

Potential biomarkers and targets of mitochondrial dynamics

机译:潜在的生物标志物和线粒体动力学的目标

获取原文
           

摘要

Mitochondrial dysfunction contributes to the imbalance of cellular homeostasis and the development of diseases, which is regulated by mitochondria‐associated factors. The present review aims to explore the process of the mitochondrial quality control system as a new source of the potential diagnostic biomarkers and/or therapeutic targets for diseases, including mitophagy, mitochondrial dynamics, interactions between mitochondria and other organelles (lipid droplets, endoplasmic reticulum, endosomes, and lysosomes), as well as the regulation and posttranscriptional modifications of mitochondrial DNA/RNA (mtDNA/mtRNA). The direct and indirect influencing factors were especially illustrated in understanding the interactions among regulators of mitochondrial dynamics. In addition, mtDNA/mtRNAs and proteomic profiles of mitochondria in various lung diseases were also discussed as an example. Thus, alternations of mitochondria‐associated regulators can be a new category of biomarkers and targets for disease diagnosis and therapy.
机译:线粒体功能障碍有助于对细胞稳态的不平衡和疾病的发展,其受线粒体相关因素调节的。目前的审查旨在探讨线粒体质量控制系统作为潜在诊断生物标志物和/或治疗靶标的疾病的新来源,包括水道,线粒体动力学,线粒体和其他细胞器之间的相互作用(脂滴,内质网,内质网,内体和溶酶体),以及线粒体DNA / RNA(MTDNA / MTRNA)的调节和术语修饰。特别说明了直接和间接影响因素,以了解线粒体动力学调节剂之间的相互作用。此外,还讨论了各种肺部疾病中线粒体的MTDNA / MTRNA和蛋白质组学谱作为一个例子。因此,线粒体相关调节剂的交替可以是一种新的生物标志物和疾病诊断和治疗的目标。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号